CROI 2020 Program and Conference Information

Poster Sessions

745 EVALUATING THE IMMY SEMI-QUANTITATIVE CrAg LFA INHIV- POSITIVE PATIENTS IN BOTSWANA Kwana Lechiile , Mark W. Tenforde, Thandi Milton, Amber Boose, Tshepo B. Leeme, Leabaneng Tawe, Charles Muthoga, Fredah Mulenga, Ikanyeng Rulaganyang, Julia Ngidi, Madisa Mine, Joseph N. Jarvis 746 HIGH RATES OFMENINGITIS ORMORTALITY AMONG CrAg+ PLHIVWITH CD4 100-200 CELLS/MM³ James H. Wykowski , Paul K. Drain, Sean Galagan, Sabina M. Govere, Connie L. Celum, Mahomed-Yunus Moosa, Carole Wallis 747 CSF CYTOKINES AND CHEMOKINES ASSOCIATEDWITH MORTALITY IN CRYPTOCOCCAL MENINGITIS Elizabeth C. Okafor , Liliane Mukaremera, Nicole Wyman Engen, Katherine Huppler Hullsiek, Lillian Tugume, Kenneth Ssebambulidde, Abdu Musubire, Edwin Nuwagira, Edward Mpoza, Darlisha A. Williams, Conrad Muzoora, David Meya, Joshua Rhein, David R. Boulware, for the ASTRO-CM Team 748 TUBERCULOSIS INHIV-ASSOCIATED CRYPTOCOCCAL MENINGITIS AND ITS IMPACT ONMORTALITY Morris K. Rutakingirwa , Fiona V. Cresswell, Enock Kagimu, Edwin Nuwagira, Kenneth Ssebambulidde, Lillian Tugume, Edward Mpoza, Joanna Dobbin, Richard Kwizera, Darlisha Williams, Conrad Muzoora, David B. Meya, David R. Boulware, Katherine Huppler Hullsiek, Joshua Rhein 749 THE GLOBAL DISTRIBUTION, DRIVERS, AND BURDEN OF TALAROMYCOSIS, 1964-2017 Chuanyi Ning , Wudi Wei, Bo Xu, Thanh T. Nguyen, Li Ye, Hao Liang, Thuy Le 750 SUPERIOR ACCURACY OF THEMp1p ANTIGEN ASSAY OVER CULTURES IN DIAGNOSING TALAROMYCOSIS Ly T. Vo , Thu T. Nguyen, Thanh T. Nguyen, Nguyen Le Nhu Tung, Jasper F. Chan, Patrick C. Woo, Chau V. Nguyen, Nga N. Cao, Kwok-Yung Yuen, Thuy Le 751 INVITRO ANTIFUNGAL SUSCEPTIBILITY AND ANTIFUNGAL TREATMENT OUTCOME IN TALAROMYCOSIS Thu T. Nguyen , Hannah Shepard, Ly T. Vo, Thanh T. Nguyen, Thuy Le 752 PREVALENCE OF CMV VIREMIA AND ASSOCIATED RISK INHIV- INFECTED PERSONS STARTING ART Shweta Sharma , Mark R. Schleiss, Hansjakob Furrer, Daniel Nixon, Mark Blackstad, Nelmary Hernandez-Alvarado, Dominic Dwyer, Álvaro H. Borges, H. Clifford Lane, Jean-Michel Molina, Jens D. Lundgren, James Neaton, for the INSIGHT and ANRS Groups 753 CMV VIREMIA IN PATIENTSWITH ADVANCED HIV INFECTION: A 48-WEEK FOLLOW-UP STUDY Paula Suanzes , Adaia Albasanz, Juliana Esperalba, Candela Fernández, Júlia Sellarés, Ariadna Torrella Domingo, Bibiana Planas, Antonio Segura, Mario Martin, Jordi Navarro, Joaquin Burgos, Adrià Curran, Esteban Ribera, Vicenç Falcó 754 RISKS OF OPPORTUNISTIC INFECTIONS FOR HIV+/- VETERANS UNDERGOING CANCER CHEMOTHERAPY Alain Makinson , Lesley S. Park, Kimberly Stone, Maria Rodriguez- Barradas, Sheldon T. Brown, Roxanne Wadia, Kristina Crothers, Cynthia L. Gibert, Roger Bedimo, Matthew B. Goetz, Fatma Shebl, Jacques Reynes, Vincent Le Moing, Keith M. Sigel

Poster Sessions • Wednesday

CROI 2020 158